Table 2. Participant time to completions for 500 kJ time trial following placebo and sodium phosphate supplementation (n = 13). FFM = free fat mass; * = average time for faster participants (n = 8); † = average time for slower participants (n = 5).
|
Placebo |
25 mg/kg FFM |
50 mg/kg FFM |
75 mg/kg FFM |
| min:s |
min:s |
min:s |
min:s |
| Participant 1* |
40:20.2 |
40:11.8 |
40:16.8 |
41:16.6 |
| Participant 2† |
44:25.2 |
47:25.2 |
42:45.0 |
46:50.6 |
| Participant 3† |
43:54.4 |
42:24.0 |
45:24.6 |
41.57.4 |
| Participant 4* |
38:36.4 |
41:25.8 |
34:48.0 |
40:14.6 |
| Participant 5* |
38:52.0 |
40:19.0 |
38:33.0 |
37:53.2 |
| Participant 6† |
56:14.0 |
57:11.0 |
54:22.2 |
52:04.6 |
| Participant 7† |
44:54.4 |
49:28.6 |
50:56.8 |
49:01.4 |
| Participant 8* |
32:07.0 |
30:25.6 |
33:51.8 |
32:10.6 |
| Participant 9* |
36:25.6 |
40:56.2 |
38:06.4 |
36:07.0 |
| Participant 10* |
30:45.4 |
32:43.6 |
28:46.8 |
29:26.2 |
| Participant 11* |
31:34.2 |
33:44.0 |
31:27.0 |
33:45.6 |
| Participant 12† |
56:02.6 |
57:32.0 |
54:25.0 |
51:19.2 |
| Participant 13* |
34:26.0 |
36:50.0 |
38:16.0 |
36:19.2 |
| Average time benefit compared to placebo for those that benefited |
- |
1 min 7 s |
1 min 25 s |
2 min 14s |
*Average time for faster participants (n = 8) 35:23.0 37:04.0 35:53.0 35:23.4†Average time for slower participants (n = 5) 50:48.2 49:34.7 48:14.0 49:05.0
